
Biotechnology • Healthcare Insurance • Pharmaceuticals
NAVERIS is a biotechnology company focused on the early detection of viral cancers through innovative technologies. Their flagship product, NavDx®, is a highly sensitive liquid biopsy that enables earlier identification and monitoring of HPV-related cancers compared to traditional methods. With a mission to improve patient outcomes and transform cancer detection, Naveris leverages proprietary technology for non-invasive blood tests that provide real-time insights into cancer recurrence and treatment responses.
11 - 50 employees
Founded 2017
🧬 Biotechnology
⚕️ Healthcare Insurance
💊 Pharmaceuticals
November 26
National Sales Trainer responsible for launching training programs for Sales Representatives at Naveris, enhancing clinical engagement in healthcare sales. Focused on NavDx diagnostic technology and multi-specialty training.
November 19
Sales Representative for Naveris promoting NavDx blood test in Southern California and Arizona. Engaging medical professionals to increase clinical awareness and market share of innovative diagnostics in oncology.